Bush Odonnell Investment Advisors Inc decreased Johnson & Johnson (JNJ) stake by 9.56% reported in 2017Q4 SEC filing. Bush Odonnell Investment Advisors Inc sold 4,740 shares as Johnson & Johnson (JNJ)’s stock declined 9.21%. The Bush Odonnell Investment Advisors Inc holds 44,826 shares with $6.26 million value, down from 49,566 last quarter. Johnson & Johnson now has $337.58 billion valuation. The stock increased 0.58% or $0.73 during the last trading session, reaching $125.86. About 1.19M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since May 16, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.
SHOPRITE HOLDINGS LTD ORD ORDINARY SHARE (OTCMKTS:SRHGF) had a decrease of 0.88% in short interest. SRHGF’s SI was 441,300 shares in May as released by FINRA. Its down 0.88% from 445,200 shares previously. With 100 avg volume, 4413 days are for SHOPRITE HOLDINGS LTD ORD ORDINARY SHARE (OTCMKTS:SRHGF)’s short sellers to cover SRHGF’s short positions. The SI to SHOPRITE HOLDINGS LTD ORD ORDINARY SHARE’s float is 0.12%. It closed at $18.87 lastly. It is down 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.
Shoprite Holdings Limited operates as a food retailer. The company has market cap of $10.70 billion. The firm operates through four divisions: Supermarkets RSA, Supermarkets Non-RSA, Furniture, and Other Operating divisions. It has a 21.64 P/E ratio. As of July 2, 2017, it operated 2301 corporate outlets and 388 franchise outlets in 15 countries across Africa and the Indian Ocean Islands.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 100 analyst reports since August 7, 2015 according to SRatingsIntel. UBS maintained the shares of JNJ in report on Thursday, August 31 with “Buy” rating. The firm has “Hold” rating given on Tuesday, September 13 by Jefferies. The firm earned “Buy” rating on Tuesday, June 13 by Cowen & Co. Jefferies maintained Johnson & Johnson (NYSE:JNJ) on Friday, April 13 with “Buy” rating. The firm has “Buy” rating given on Friday, January 12 by Wells Fargo. The stock has “Hold” rating by Jefferies on Tuesday, June 14. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by BMO Capital Markets on Thursday, August 31. On Wednesday, April 18 the stock rating was maintained by Deutsche Bank with “Buy”. The stock has “Sell” rating by Standpoint Research on Friday, May 20. Argus Research maintained the shares of JNJ in report on Wednesday, April 20 with “Buy” rating.
Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.04, from 0.83 in 2017Q3. It increased, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. The Massachusetts-based Panagora Asset has invested 0.74% in Johnson & Johnson (NYSE:JNJ). Barnett Incorporated accumulated 0.07% or 962 shares. Seabridge Advsr Limited Liability Corporation holds 0% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 125 shares. Staley Capital Advisers owns 197,953 shares. Qs Investors Lc holds 240,533 shares or 0.32% of its portfolio. One Ltd Limited Liability Company holds 0.73% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 26,052 shares. Thompson Siegel And Walmsley Ltd reported 96,663 shares. Norinchukin Bank & Trust The reported 1.12% stake. Saybrook Capital Nc reported 59,482 shares or 3.84% of all its holdings. Caisse De Depot Et Placement Du Quebec stated it has 4.75M shares or 1.53% of all its holdings. Moody National Bank & Trust Division has invested 0.24% in Johnson & Johnson (NYSE:JNJ). Amica Mutual Ins reported 129,363 shares. Jarislowsky Fraser Limited has 1.56 million shares for 1.27% of their portfolio. Essex Fin stated it has 3.18% of its portfolio in Johnson & Johnson (NYSE:JNJ). Stadion Money Mngmt Ltd Llc, a Georgia-based fund reported 13,089 shares.
Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.05 earnings per share, up 12.02% or $0.22 from last year’s $1.83 per share. JNJ’s profit will be $5.50 billion for 15.35 P/E if the $2.05 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -0.49% negative EPS growth.
More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “What Can I Expect To Make If I Invest In Johnson & Johnson Today?” on May 16, 2018, also Seekingalpha.com with their article: “Johnson & Johnson: Waiting On The Wave” published on May 11, 2018, Seekingalpha.com published: “Johnson & Johnson Sells Off After Earnings” on April 22, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: 247Wallst.com and their article: “Johnson & Johnson Commits to Yet Another Dividend Hike” published on April 26, 2018 as well as Seekingalpha.com‘s news article titled: “Retirement Strategy: I Am Done Being Wrong About This Market” with publication date: May 16, 2018.
Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $20.17 million activity. $20.17M worth of stock was sold by Stoffels Paulus on Thursday, February 15.